| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
JD
|
92.96 | 4.4B | 10.20 | 1.49 | 4.07 | 15.5% | 11.0% | 70 | 40 | 142.67 | +38.5% | 64 | 1.23 |
|
KGF
|
324.80 | 5.3B | 21.69 | 0.86 | 6.18 | 5.6% | 12.8% | 62 | 27 | 440.28 | +25.6% | 63 | 0.38 |
|
SBRY
|
334.70 | 7.3B | 18.55 | 1.19 | 5.86 | 7.5% | 10.8% | 61 | 36 | 414.76 | +16.0% | 54 | 1.07 |
|
NXT
|
15,135.00 | 17.3B | 19.45 | 10.39 | 11.69 | 35.5% | 13.3% | 56 | 40 | 8,889.52 | -30.9% | 77 | 1.09 |
|
TSCO
|
447.00 | 27.8B | 15.58 | 2.43 | 8.00 | 12.1% | 10.9% | 56 | 31 | 415.84 | -4.7% | 55 | 1.32 |
|
MKS
|
384.50 | 8.0B | 30.67 | 2.60 | 7.92 | 16.6% | 12.9% | 44 | 36 | 283.45 | -18.9% | 63 | 1.12 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.